Demographics and outcomes of hemoglobin genotype in hospitalized patients with COVID-19 and sickle cell disease in the United States.

Nosakhare Paul IlerhunmwuwaLawrence InyangMustafa WasifuddinHenry AiwuyoMuhammad TahirNarek HakobyanPaul AnkahBeatrice E TorereUchenna M AmaechiAditya Keerthi RayapureddyJen-Chin Wang

Published in: European journal of haematology (2023)

There is no difference in COVID-19 outcomes among Hb genotypes in SCD. Further studies are needed to explore the reasons for this observation.

Keyphrases

sickle cell disease
coronavirus disease
sars cov
type diabetes
red blood cell
adipose tissue
skeletal muscle
weight loss